As a unique process in the pancreas since KRAS dependent tumor development in lung and colon do not rely on EGFR signaling [32], EGFR activation synergistically supports the robust MEK/ERK and KRAS activities that are necessary for ADM formation but cannot be achieved solely by a single mutated Kras allele [3]. The gene discussed is KRAS; the disease is neoplasm.